Mohanad Shkoor

Dr. Mohanad Shkoor

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2017 in ACS Catalysis
Verified
Journal Article
Closed access
THTaoufik Ben Halima
Taoufik Ben Halima
JVJaya Kishore Vandavasi
Jaya Kishore Vandavasi
MSMohanad Shkoor
Mohanad Shkoor
SNStephen G. Newman
Stephen G. Newman

2 June 2022 in Journal of the American Chemical Society
Verified
Journal Article
Open access
MJMichał Jakubczyk
Michał Jakubczyk
SMSatenik Mkrtchyan
Satenik Mkrtchyan
MSMohanad Shkoor
Mohanad Shkoor
SLSuneel Lanka
Suneel Lanka
SBSimon Budzak
Simon Budzak
Viktor IaroshenkoViktor Iaroshenko
Viktor Iaroshenko
Increased interest in the trifluoromethoxy group in organic synthesis and medicinal chemistry has induced a demand for new, selective, general, and faster methods applicable to natural products and highly functionalized compounds at a later stage of hit-to-lead campaigns. Applying pyrylium tetrafluoroborate, we have developed a mechanochemical protocol to selectively substitute the aromatic amino group with the OCF3 functionality. The scope of our method includes 31 examples of ring-substituted anilines, including amides and sulfonamides. Expected SNAr products were obtained in excellent yields. The presented concise method opens a pathway to new chemical spaces for the pharmaceutical industry.

15 June 2023 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
MAMothana K. Al-Omari
Mothana K. Al-Omari
MEMai Elaarag
Mai Elaarag
ASAlrayyan Private school
Alrayyan Private school
AAAhmad Al-Qudimat
Ahmad Al-Qudimat
AZAyman A. Zarour
Ayman A. Zarour
AAAbdulla A. Al-Ansari
Abdulla A. Al-Ansari
Boronic acids/esters have recently emerged in the field of medicinal and pharmaceutical research due to their exceptional oxophilicity, low toxicity, and unique structure. They are known as potent enzyme inhibitors, cancer therapy capture agents, and can mimic certain types of antibodies to fight infections. They have been designed and developed into drugs, and this approach has emerged in the last 20 years. Five boronic acid drugs have been approved by the FDA and Health Canada, two of which are used to treat cancer, specifically multiple myeloma. The purpose of this review is to investigate boronic acid/ester derivatives as potential pharmaceutical agents as well as the mechanism of action. It will concentrate on six types of cancer: multiple myeloma, prostate cancer, breast cancer, lung cancer, cervical cancer, and colon cancer. Some newly developed boron-containing compounds have already demonstrated highly promising activities, but further investigation is required before final conclusions can be drawn.

1 September 2020 in Journal of Molecular Liquids
Verified
Journal Article
Open access
MSMohanad Shkoor
Mohanad Shkoor
HMHanin Mehanna
Hanin Mehanna
ASAyaa Shabana
Ayaa Shabana
TFToka Farhat
Toka Farhat
ABAbdulilah Dawoud Bani-Yaseen
Abdulilah Dawoud Bani-Yaseen

9 January 2023 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
SMSatenik Mkrtchyan
Satenik Mkrtchyan
MSMohanad Shkoor
Mohanad Shkoor
MPMandalaparthi Phanindrudu
Mandalaparthi Phanindrudu
MMMiroslav Medved′
Miroslav Medved′
OSOlena Sevastyanova
Olena Sevastyanova
Viktor IaroshenkoViktor Iaroshenko
Viktor Iaroshenko
The amide bond is prominent in natural and synthetic organic molecules endowed with activity in various fields. Among a wide array of amide synthetic methods, substitution on a pre-existing (O)C-N moiety is an underexplored strategy for the synthesis of amides. In this work, we disclose a new protocol for the defluorinative arylation of aliphatic and aromatic trifluoroacetamides yielding aromatic amides. The mechanochemically induced reaction of either arylboronic acids, trimethoxyphenylsilanes, diaryliodonium salts, or dimethyl(phenyl)sulfonium salts with trifluoroacetamides affords substituted aromatic amides in good to excellent yields. These nickel-catalyzed reactions are enabled by C-CF3 bond activation using Dy2O3 as an additive. The current protocol provides versatile and scalable routes for accessing a wide variety of substituted aromatic amides. Moreover, the protocol described in this work overcomes the drawbacks and limitations in the previously reported methods.

22 September 2023 in Heliyon
Verified
Journal Article
Open access
MSMohanad Shkoor
Mohanad Shkoor
RJRem Jalab
Rem Jalab
MKMazen Khaled
Mazen Khaled
TSTahseen S. Shawkat
Tahseen S. Shawkat
HKHesham M. Korashy
Hesham M. Korashy
ABAbdulilah Bani-Yaseen
Abdulilah Bani-Yaseen
A novel bis-phenylurea-based aliphatic amine (BPUA) was prepared via a facile synthetic route, and evaluated as a potential green organic corrosion inhibitor for carbon steel in 1.0 M HCl solutions. NMR spectroscopy experiments confirmed the preparation of the targeted structure. The corrosion inhibitory behavior of the prospective green compound was explored experimentally by electrochemical methods and theoretically by DFT-based quantum chemical calculations. Obtained results revealed an outstanding performance of BPUA, with efficiency of 95.1% at the inhibitor concentration of 50 mg L−1 at 25 °C. The novel compound has improved the steel resistivity and noticeably reduced the corrosion rate from 33 to 1.7 mils per year. Furthermore, the adsorption study elucidates that the mechanism of the corrosion inhibition activity obeys Langmuir isotherm with mixed physisorption/chemisorption modes for BPUA derivatives on the steel surface. Calculated Gibb's free energy of the adsorption process ranges from −35 to −37 kJ mol−1.